Our vision is to promote the widest possible access to generic and biosimilar medicines with high quality, safety and efficacy, support international harmonized pathways for the registration of those medicines, and a strong commitment by members to standards agreed by the International Council for Harmonization (ICH) and WHO accredited regulators.
News
In an era when increasing demands are being made on the world’s healthcare services, generic and biosimilar medicines provide a major benefit to society by ensuring patient access to quality, safe and effective medicines while reducing the cost of pharmaceutical care.
The International Generic Pharmaceutical Alliance (IGPA) was founded in March 1997 as an international network of generic medicines associations. To reflect the evolving nature of the industry, in September 2015, IGPA incorporated under Swiss Law, and at the same time changed the name of the organization to the International Generic and Biosimilar Medicines Association (IGBA).
The Ritz-Carlton Key Biscayne, Miami
Key Biscayne, FL
November 19 - 21, 2014
November 19-21, 2014: Join us for the 17th Annual IGPA Conference! The biggest conference gathering of the global generic industry, attracting attendees from around the globe. It will convene at the beautiful Key Biscayne, Florida. The program agenda provides a unique forum for generic pharmaceutical executives from around the world to network and hear world-renowned experts discussing the latest insight into the international commercial, legal, and regulatory developments concerning the generic pharmaceutical sector. Register Today!
